Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-5,192
Closed -$249K 392
2015
Q4
$249K Sell
5,192
-13,126
-72% -$593K 0.02% 425
2015
Q3
$754K Sell
18,318
-7,154
-28% -$332K 0.02% 424
2015
Q2
$1.23M Sell
25,472
-10,848
-30% -$518K 0.02% 425
2015
Q1
$1.68M Buy
36,320
+1,283
+4% +$57.8K 0.03% 367
2014
Q4
$1.51M Buy
35,037
+113
+0.3% +$4.58K 0.03% 356
2014
Q3
$1.29M Buy
34,924
+5,114
+17% +$175K 0.02% 379
2014
Q2
$962K Buy
29,810
+11,516
+63% +$353K 0.02% 446
2014
Q1
$529K Buy
18,294
+938
+5% +$28.6K 0.01% 542
2013
Q4
$567K Sell
17,356
-79
-0.5% -$2.52K 0.01% 487
2013
Q3
$543K Buy
17,435
+2,925
+20% +$89.6K 0.01% 495
2013
Q2
$448K Buy
+14,510
New +$470K 0.01% 499

Other funds holding ZTS

Curian Capital's ZTS Position: Q1 2016 in Review

Curian Capital sold out of Zoetis (ZTS) in Q1 2016, closing a stake of 5,192 shares — an estimated $249K sold.

Curian Capital first reported a position in ZTS in Q2 2013 and held it in 11 quarters. The position peaked at $1.68M in Q1 2015. 613 funds tracked by Wall St. Rank hold ZTS as of Q1 2016.

  • Curian Capital reported no remaining Zoetis position as of Q1 2016 after selling out during the quarter.
  • Curian Capital sold 5,192 Zoetis shares in Q1 2016, an estimated $249K.
  • Curian Capital first reported a position in Zoetis in Q2 2013 and held it in 11 quarters.
  • Curian Capital's Zoetis position peaked at $1.68M in Q1 2015.
  • 613 funds tracked by Wall St. Rank held Zoetis as of Q1 2016.

Based on Curian Capital's 13F filing for Q1 2016.